2006 publications

 - Chung KY, Morrone G, Schuringa JJ, Plasilova M, Shieh JH, Zhang Y, Zhou P, Moore MA. Enforced expression of NUP98-HOXA9 in human CD34(+) cells enhances stem cell proliferation. Cancer Res. 2006 Dec 15;66(24):11781-91.

 

- Schepers H, Eggen BJ, Schuringa JJ, Vellenga E . Constitutive activation of NF-kappa B is not sufficient to disturb normal steady-state hematopoiesis. Haematologica. 2006 Dec;91(12):1710-1.

 

- Heijink IH, Kies PM, van Oosterhout AJ, Postma DS, Kauffman HF, Vellenga E. Der p, IL-4 and TGF-{beta} Cooperatively Induce EGFR-dependent TARC Expression in Airway Epithelium. Am J Respir Cell Mol Biol. 2006 Oct 5; [Epub ahead of print]

 

- Agool A, Schot BW, Jager PL, Vellenga E. 18F-FLT PET in Hematologic Disorders: A Novel Technique to Analyze the Bone Marrow Compartment. J Nucl Med. 2006 Oct;47(10):1592-1598.

 

- Schot BW, Zijlstra JM, Sluiter WJ, van Imhoff GW, Pruim J, Vaalburg W, Vellenga E. Early FDG-PET assessment in combination with clinical risk scores determines prognosis in relapsed lymphoma. Blood. 2006 Sep 26; [Epub ahead of print]

 

- Rizo A, Vellenga E, de Haan G, Schuringa JJ. Signaling pathways in self-renewing hematopoietic and leukemic stem cells: do all stem cells need a niche? Hum Mol Genet. 2006 Oct 15;15 Suppl 2:R210-9.

 

- Peeters SD, van der Kolk DM, de Haan G, Bystrykh L, Kuipers F, de Vries EG, Vellenga E. Selective expression of cholesterol metabolism genes in normal CD34+CD38- cells with a heterogeneous expression pattern in AML cells. Exp Hematol. 2006 May;34(5):622-30.

 

- Schot BW, Pruim J, van Imhoff GW, Sluiter WJ, Vaalburg W, Vellenga E . The role of serial pre-transplantation positron emission tomography in predicting progressive disease in relapsed lymphoma.
Haematologica. 2006 Apr;91(4):490-5. Epub 2006 Mar 1. 

 

- Wierenga AT, Schepers H, Moore MA, Vellenga E, Schuringa JJ. STAT5-induced self-renewal and impaired myelopoiesis of human hematopoietic stem/progenitor cells involves downmodulation of C/EBP{alpha}
2006 Jun 1;107(11):4326-33

 

- Peeters SD, van der Kolk DM, de Haan G, Bystrykh L, Kuipers F, de Vries EG, Vellenga E . Selective expression of cholesterol metabolism genes in normal CD34+CD38- cells with a heterogeneous expression pattern in AML cells. Exp Hematol. 2006 May;34(5):622-30

 

- Drayer, AL, Olthof SG, Vellenga, E. Mammalian target of rapamycin is required for thrombopoietin-induced proliferation of megakaryocyte progenitors. Stem Cells 2006 Jan;24(1):105-14. Epub 2005 Aug 25.